AUA
  • Program
  • Register
  • Meeting Coverage
  • Guidelines
  • Industry Highlights
  • Science & Technology Hall
Topics
  • Meeting Coverage
  • Guidelines
  • Industry Highlights
  • Science & Technology Hall
Resources
  • Program
  • Register
Twitter X icon Facebook iconInstagram iconYouTube iconLinkedIn icon
Apr 28, 2023

Urologists must start the conversation about genitourinary syndrome of menopause

Fewer than 6% of women with GSM signs and symptoms are being treated.


Mg 1043

Genitourinary syndrome of menopause (GSM), a spectrum of symptoms and signs caused by hypoestrogenic changes in urogenital tissues typically occurring during menopause, affects up to 87% of postmenopausal women. The discomfort, pain and irritation in symptomatic women can greatly impact their quality of life, including their sexual function and interpersonal relationships. Yet fewer than 6% of women with GSM signs and symptoms are being treated.

“An unfortunate barrier to treatment is that women believe symptoms of GSM are a normal consequence of aging they must accept,” said Melissa R. Kaufman, MD, PhD, FACS, chair of urological surgery at Vanderbilt University Medical Center. “As a result, women rarely discuss symptoms with their health care provider, and providers do not consistently ask about symptoms.”

It’s time for urologists to start the conversation.          

“Urologists need to stand up and get really loud about GSM and educate patients and other providers about it,” said Rachel S. Rubin, MD, during Friday’s Instructional Course, “Navigating Genitourinary Syndrome of Menopause: Path to Patient Satisfaction.” The course synthesized the totality of evidence available on the benefits and harms of screening, diagnosing and treating GSM to inform decision-making for health care professionals and clinicians. “We have a unique opportunity to make this about the bladder,” said Dr. Rubin, who is a board-certified urologist with fellowship training in sexual medicine.

The deficit of estrogen in menopause creates a cascade of effects, including a change in the microbiota and in the anatomy of the vagina, that can increase the risk of infection in the urinary tract, said Una J. Lee, MD, head of urology and renal transplantation and urology physician lead at Virginia Mason Franciscan Health.

Symptoms of GSM may include vulvovaginal dryness, pain during intercourse, vaginal irritation/discomfort, itching, pain during exercise, tenderness and bleeding related to intercourse. Urinary symptoms include urgency, dysuria, recurrent urinary tract infections, urge incontinence and stress incontinence. Signs can include decreased moisture and elasticity, labia minora resorption, loss of vaginal rugae and urethral eversion or prolapse.

Localized vaginal estrogen creams, inserts and rings are Food and Drug Administration-approved treatment options that are safe and effective.

“Vaginal hormones are the foundation of treatment,” Dr. Rubin said. “Patient education is essential for adherence.” GSM is progressive. To maintain healthy vaginal tissue, patients will need to refill their vaginal estrogen prescription indefinitely.        

The AUA is in the process of developing a clinical practice guideline based on an independent systematic review of the evidence.

“GSM guidelines will change the landscape,” Dr. Kaufman said. “We have to own it.”

Interesting Stories
Don’t miss a thing with AUANews
Sponsored by AUA
Don’t miss a thing with AUANews
Pacific Edge Announces Key Activities at AUA2023
Sponsored by Pacific Edge Diagnostics
Pacific Edge Announces Key Activities at AUA2023
Check out the AUA’s brand new Gold Open Access journal, JU Open Plus
Sponsored by AUA
Check out the AUA’s brand new Gold Open Access journal, JU Open Plus
Reshaping BPH Treatment with the iTind™ Procedure
Sponsored by Olympus
Reshaping BPH Treatment with the iTind™ Procedure
More Content
Getty Images 910070326
Meeting Coverage
Saddle up for AUA2024 in San Antonio
May 11, 2023
Getty Images 1400488393
Meeting Coverage
Healthy debates
May 11, 2023
Getty Images 1345835999
Meeting Coverage
Claim your CME
May 11, 2023
Screen Shot 2023 05 10 At 12 15 03 Pm
Meeting Coverage
Must-see TV
May 11, 2023
Screen Shot 2023 05 02 At 4 48 03 Pm
Meeting Coverage
Read all about it
May 11, 2023
Guide And Rec
Meeting Coverage
Medical guidelines and recommendations take center stage at AUA2023
May 05, 2023
Yeonsoo Sara Lee, BS, medical student
Meeting Coverage
AUA2023 through the eyes of an MD candidate
May 05, 2023
Screen Shot 2023 05 03 At 1 16 42 Pm
Meeting Coverage
AUA2023 On Demand
May 05, 2023
Peter R. Carroll, MD, MPH
Meeting Coverage
Accolades in urology
May 05, 2023
Screen Shot 2023 05 02 At 4 48 33 Pm
Meeting Coverage
Mark your calendars for AUA2024
May 05, 2023
Screen Shot 2023 05 02 At 4 48 03 Pm
Meeting Coverage
Read all about it
May 05, 2023
Isla P. Garraway, MD, PhD
Meeting Coverage
Genetic testing key to targeting prostate cancer
Apr 30, 2023
AUA
Twitter X icon Facebook iconInstagram iconYouTube iconLinkedIn icon
© 2023 Ascend Media. All rights reserved.